Skip to main content
Normal View

Medicinal Products Licensing

Dáil Éireann Debate, Tuesday - 25 February 2014

Tuesday, 25 February 2014

Questions (634)

Seán Ó Fearghaíl

Question:

634. Deputy Seán Ó Fearghaíl asked the Minister for Health the total number of serious adverse reactions to Lariam, using the strict medical definition of "serious", reported to the Irish Medicines Board, where the symptoms have persisted for less than a year, where symptoms have persisted for more than one year but less than three, where symptoms have persisted for more than three years but have now resolved, and where symptoms have persisted for more than three years, have still not resolved and where a serious adverse reaction was reported but the IMB has no follow-up data on whether these symptoms persist or have resolved; and if he will make a statement on the matter. [8896/14]

View answer

Written answers

The Irish Medicines Board is the statutory body responsible for the authorisation of marketing permission for pharmaceutical products and the monitoring of possible adverse reactions to such products. Therefore, I have asked the IMB to reply directly to the Deputy in this regard.

Top
Share